Dr. Bansal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12330 Metcalf Ave
Ste 580
Overland Park, KS 66213Phone+1 816-932-3300Fax+1 816-932-5793
Education & Training
- University of New Mexico School of MedicineResidency, Internal Medicine, 2008 - 2011
- N.H.L Municipal Medical CollegeClass of 2006
Certifications & Licensure
- MO State Medical License 2013 - 2026
- KS State Medical License 2021 - 2025
- OR State Medical License 2024 - 2025
- CA State Medical License 2017 - 2020
- IL State Medical License 2011 - 2017
- NM State Medical License 2007 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Long-Term Survival by Number of Immune Checkpoint Inhibitors in PD-L1-Negative Metastatic NSCLC: A Systematic Review and Meta-Analysis.Ben Ponvilawan, Dhruv Bansal, Nagla Abdel Karim, Rahul Ramakrishnan, Janakiraman Subramanian
JAMA Network Open. 2025-02-03 - 3 citationsAssociation of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, Vasily N Aushev, Abdullah Esmail
The Oncologist. 2024-10-03 - The Number of Chemoimmunotherapy Cycles and Clinical Outcomes in Resectable NSCLC.Ben Ponvilawan, Janakiraman Subramanian, Dhruv Bansal
Journal of Thoracic Oncology. 2024-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: